WallStreetZen

NYSE: NVS
Novartis Ag Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

NVS past earnings growth

How has NVS's earnings growth performed historically?
Company
-34.09%
Industry
13.49%
Market
77.49%
NVS's earnings have grown slower (4.19% per year) than the US Drug Manufacturers - General industry average (7.58%)
Performance
NVS's earnings have grown slower (4.19% per year) than the US market average (20.98%)
Performance
NVS's earnings growth is slowing down - its growth over the last year (-34.09%) is below its 5-year compound annual rate (4.19%)
Performance

NVS past revenue growth

How has NVS's revenue growth performed historically?
Company
-0.09%
Industry
11.58%
Market
28.71%
NVS's revenue has grown slower (-0.04% per year) than the US Drug Manufacturers - General industry average (4.72%)
Performance
NVS's revenue has grown slower (-0.04% per year) than the US market average (16.77%)
Performance
NVS's revenue growth is slowing down - its growth over the last year (-0.09%) is below its 5-year compound annual rate (-0.04%)
Performance

NVS earnings and revenue history

Current Revenue
$49.9B
Current Earnings
$8.0B
Current Profit Margin
15.9%
NVS's has not demonstrated consistent long-term earnings growth over the past 10 years (-16.67%)
Performance

NVS Return on equity

Current Company
14.8%
Current Industry
31.9%
Current Market
31.1%
NVS's Return on Equity (14.8%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

NVS Return on assets

Current Company
6.3%
Current Industry
6.8%
Current Market
6.5%
NVS is generating lower Return on Assets (6.3%) than the US Drug Manufacturers - General industry average (7.04%)
Performance

NVS Return on capital employed

Current Company
11.5%
Current Industry
11.3%
NVS has gotten more efficient at generating Return on Capital (11.5%) compared to 3 years ago (9.82%)
Performance

Novartis Ag Earnings & Revenue FAQ

What were NVS's earnings last quarter?

Novartis Ag (NYSE: NVS) reported Q1 2021 earnings per share (EPS) of $0.91, up 5.21% year over year. Total Novartis Ag earnings for the quarter were $2.06 billion. In the same quarter last year, Novartis Ag's earnings per share (EPS) was $0.96.

What was NVS's earnings growth in the past year?

As of Q2 2021, Novartis Ag's earnings has grown -34.09% year over year. This is 47.58 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 13.49%. Novartis Ag's earnings in the past year totalled $7.96 billion.

What was NVS's revenue last quarter?

Novartis Ag (NYSE: NVS) reported Q1 2021 revenue of $12.69 billion up 0.11% year over year. In the same quarter last year, Novartis Ag's revenue was $12.71 billion.

What was NVS's revenue growth in the past year?

As of Q2 2021, Novartis Ag's revenue has grown -0.09% year over year. This is 11.68 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 11.58%. Novartis Ag's revenue in the past year totalled $49.88 billion.
©2021 WallStreetZen
Company
AboutBlogPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.